Daniel McCormick, originally from Wake County, North Carolina, stands out as a distinguished leader in the global commercial sector, holding substantial roles as a general manager with a particular focus on sales, marketing leadership, operations, planning, and strategizing. His journey spans over 25 years, predominantly in the biotechnology, pharmaceutical, diagnostics, and medical device sectors, establishing him as a well-versed professional in these industries. His journey has also seen him embrace the role of a Marine officer, a position that has significantly influenced his leadership style. He is widely revered among his colleagues for his unwavering commitment to a people-centric approach, consistently demonstrating a profound sense of responsibility and accountability. These traits have not gone unnoticed, as he has received numerous accolades for his visionary leadership and exceptional ability to drive productivity within his teams. When he’s not immersed in his professional responsibilities, he devotes his time to his family, being a devoted husband and father to four children. He also indulges in his passion for basketball, scuba diving, and international travel, ensuring a well-rounded and balanced life.
He plays a pivotal role at Zensights, a biotech and pharmaceutical consulting firm based in Scottsdale, Arizona. Since joining the firm in September 2022 as its principal, he has forged dynamic partnerships with leading industry partners, facilitating capability-specific connections between biopharmaceutical companies. His leadership at Zensights is characterized by a commitment to innovation, agility, and cost-effectiveness, striving to create enduring and mutually beneficial client relationships. In addition to his work at Zensights, he serves as the president of Generis Global Solutions, a specialized management consulting firm in Raleigh, North Carolina. Since taking on this role in 2018, he has been at the forefront of aiding growth-oriented companies and other organizations within the life sciences industry to develop efficient and effective operations. His efforts at Generis are centered around driving incremental revenues across various global markets and building and operationalizing innovative commercial and medical affairs models, all while ensuring optimal impact and return on investment.
